Daiwa Securities Group Inc. Stoke Therapeutics, Inc. Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 175 shares of STOK stock, worth $5,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175
Previous 175
-0.0%
Holding current value
$5,309
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding STOK
# of Institutions
138Shares Held
58MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$164 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$164 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$155 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$141 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$133 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.2B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...